DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Sanofi India Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·5 Aug 2026, 7:41 am

Sanofi India

Sanofi India has announced an investor and analyst meeting to discuss its recent performance and future outlook. The company will likely use this platform to provide an update on its business strategy, product pipeline, and financial targets for the coming year.

This update is significant for investors as it offers a direct insight into management's confidence and plans. It helps retail investors gauge the company's direction and potential growth drivers beyond the standard quarterly results.

Investors should watch for details on key product launches, pricing strategies, and any guidance provided regarding market share and profitability. This information will be crucial for assessing the stock's near-term prospects.